Author

Ji Hyun Lee

Institution: Dong-A University

Observed institution: Dong-A University

ORCID: 0000-0003-2341-4911

Observed ORCID: 0000-0003-2341-4911

OpenAlex ID: A5148722768

A review of the clinical efficacy of monoclonal antibody (mAb)-based therapies for relapsed/refractory multiple myeloma (RRMM)

2026 · Yuxin Liu, Ji Hyun Lee, et al. · Expert Opinion on Biological Therapy · 2

POSTER: TCL-416: Updated Clinical Data From the Phase 1/2 Study of Dibotatug (DR-01), a Non-Fucosylated Anti-CD94 Antibody, in Patients With Relapsed/Refractory Cytotoxic T/NK Cell Lymphomas

2026 · Swaminathan Iyer, Christina Poh, et al. · Clinical Lymphoma Myeloma & Leukemia

TCL-416: Updated Clinical Data From the Phase 1/2 Study of Dibotatug (DR-01), a Non-Fucosylated Anti-CD94 Antibody, in Patients With Relapsed/Refractory Cytotoxic T/NK Cell Lymphomas

2026 · Swaminathan Iyer, Christina Poh, et al. · Clinical Lymphoma Myeloma & Leukemia

Works count: 3

Citation count: 2

H-index: 1

I10-index: